The Impact of COVID-19 Vaccination on the Social Participation of Immunocompromised Persons - Results of a Multicenter Observational Study.

COVID-19 vaccination immunocompromised observational study pandemic (COVID-19) social participation

Journal

Frontiers in public health
ISSN: 2296-2565
Titre abrégé: Front Public Health
Pays: Switzerland
ID NLM: 101616579

Informations de publication

Date de publication:
2022
Historique:
received: 16 02 2022
accepted: 19 05 2022
entrez: 27 6 2022
pubmed: 28 6 2022
medline: 29 6 2022
Statut: epublish

Résumé

Immunocompromised persons are at an increased risk for a severe SARS-CoV-2 infection and their safety behaviors may influence their social participation. Vaccinated persons have a lower incidence of infection and severe disease when infected compared to non-vaccinated persons. Therefore, their behavior may change and their social participation may increase after a complete vaccination. The aim of this study was to explore social participation of immunocompromised persons before and after complete COVID-19 vaccination. Between March and September 2021, 274 immunocompromised participants were recruited. Survey data were collected at baseline and follow-up from 194 participants including the Index for the Assessment of Health Impairments [IMET], Patient Health Questionnaire-4 [PHQ-4], subjective health status and quality of life. At baseline, participants were not yet completely vaccinated. Complete vaccination was achieved prior to the follow-up questionnaire. IMET scores decreased significantly at follow-up, indicating a higher social participation after complete vaccination. PHQ-4, subjective health status and quality of life did not differ between baseline and follow-up. There were no significant differences across sociodemographic factors. Significant PHQ-4 differences were observed regarding the population size of the participants' home community. Social participation of immunocompromised persons in our study increased after COVID-19 vaccination. Therefore, social participation should be explored further, especially with regards to the impact of vaccination on groups with a high health risk.

Identifiants

pubmed: 35757603
doi: 10.3389/fpubh.2022.877623
pmc: PMC9226413
doi:

Substances chimiques

COVID-19 Vaccines 0

Types de publication

Journal Article Multicenter Study Observational Study Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

877623

Informations de copyright

Copyright © 2022 Heesen, Schröder, Müller, Hummers, Klawonn, Mikuteit, Niewolik, Steffens, Cossmann, Behrens, Dopfer-Jablonka and Heinemann.

Déclaration de conflit d'intérêts

The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.

Références

J Nutr Health Aging. 2021;25(9):1070-1075
pubmed: 34725663
Int J Environ Res Public Health. 2021 Jan 23;18(3):
pubmed: 33498662
J Health Monit. 2021 Apr 30;6(Suppl 4):2-37
pubmed: 35586562
Rev Bras Enferm. 2019 Jan-Feb;72(1):241-247
pubmed: 30916291
Dtsch Arztebl Int. 2020 Feb 7;117(6):89-96
pubmed: 32102728
Euro Surveill. 2022 Jan;27(1):
pubmed: 34991776
J Affect Disord. 2009 Apr;114(1-3):163-73
pubmed: 18752852
Int J Environ Res Public Health. 2020 Aug 27;17(17):
pubmed: 32867287
Rehabilitation (Stuttg). 2015 Dec;54(6):402-8
pubmed: 26676739
J Prim Care Community Health. 2021 Jan-Dec;12:2150132721996898
pubmed: 33719697
SSM Popul Health. 2019 Jun 22;8:100424
pubmed: 31312713
Clin Rehabil. 2014 Mar;28(3):211-20
pubmed: 23988324
J Med Virol. 2021 Oct;93(10):5768-5776
pubmed: 34042195
J Affect Disord. 2010 Apr;122(1-2):86-95
pubmed: 19616305
BMC Public Health. 2020 Oct 21;20(1):1589
pubmed: 33087109
Rehabilitation (Stuttg). 2017 Feb;56(1):22-30
pubmed: 28219098
EClinicalMedicine. 2021 Nov;41:101158
pubmed: 34693234
Geriatr Nurs. 2022 Mar-Apr;44:8-14
pubmed: 34999368
Soc Psychiatry Psychiatr Epidemiol. 2021 Aug;56(8):1459-1468
pubmed: 33569650
Brain Behav. 2021 Nov;11(11):e2382
pubmed: 34661977
BMC Infect Dis. 2022 Apr 25;22(1):403
pubmed: 35468758

Auteurs

Gloria Heesen (G)

Department of General Practice, University Medical Center, Göttingen, Germany.

Dominik Schröder (D)

Department of General Practice, University Medical Center, Göttingen, Germany.

Frank Müller (F)

Department of General Practice, University Medical Center, Göttingen, Germany.

Eva Hummers (E)

Department of General Practice, University Medical Center, Göttingen, Germany.

Frank Klawonn (F)

Department of Computer Science, Ostfalia University of Applied Sciences, Wolfenbuettel, Germany.
Biostatistics Group, Helmholtz Centre for Infection Research, Braunschweig, Germany.

Marie Mikuteit (M)

Department of Rheumatology and Immunology, Hannover Medical School, Germany.

Jacqueline Niewolik (J)

Department of Rheumatology and Immunology, Hannover Medical School, Germany.

Sandra Steffens (S)

Department of Rheumatology and Immunology, Hannover Medical School, Germany.

Anne Cossmann (A)

Department of Rheumatology and Immunology, Hannover Medical School, Germany.

Georg Behrens (G)

Department of Rheumatology and Immunology, Hannover Medical School, Germany.

Alexandra Dopfer-Jablonka (A)

Department of Rheumatology and Immunology, Hannover Medical School, Germany.
German Center for Infection Research (DZIF), Partner Site Hannover-Braunschweig, Heidelberg, Germany.

Stephanie Heinemann (S)

Department of General Practice, University Medical Center, Göttingen, Germany.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH